Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02470676

Cervical Pessary vs Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial

Cervical Pessary vs. Vaginal Progesterone in Preventing Preterm Birth Among Women Presenting With Short Cervix: An Open-label Randomized Controlled Trial

Sponsor: Hillel Yaffe Medical Center

Conditions Preterm Birth Short Cervix

Interventions Pessary Progesterone

Updated 6 times since 2017 Last updated: Jun 9, 2015 Started: Jul 31, 2015 Primary completion: Jul 31, 2018 Completion: Jul 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02470676, this PHASE2/PHASE3 trial focuses on Preterm Birth and Short Cervix and remains ongoing. Sponsored by Hillel Yaffe Medical Center, it has been updated 6 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Aug 2019 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

Status: Not Yet Recruiting → Unknown Status
Jun 2018 — Aug 2019 [monthly]

Not Yet Recruiting PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Not Yet Recruiting PHASE2_PHASE3

First recorded

Jul 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hillel Yaffe Medical Center

Data source: Hillel Yaffe Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.